Patents Assigned to Vifor Fresenius Medical Care Renal Pharma Ltd.
  • METHOD OF MANUFACTURING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220387327
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phophate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Application
    Filed: August 18, 2022
    Publication date: December 8, 2022
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Laurent CHOFFLON, Erik PHILIPP
  • PARTICLES OF A MIXTURE OF IRON(III)-OXYHYDROXIDE, SUCROSE AND ONE OR MORE STARCHES, PREFERABLY OF SUCROFERRIC OXYHYDROXIDE
    Publication number: 20220370494
    Abstract: The invention relates to particles of a mixture of iron(III)-oxyhydroxide, sucrose and one or more starches, preferably of sucroferric oxyhydroxide having a certain particle size distribution, a process for the manufacture thereof, the pharmaceutical composition comprising the same, in particular compressed tablets.
    Type: Application
    Filed: January 14, 2021
    Publication date: November 24, 2022
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Nicolas FRISON, Miriam SPICHIGER, Mélanie ITTEL
  • Pharmaceutical composition, comprising phosphate binder particles
    Patent number: 11446252
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: September 20, 2022
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd.
    Inventors: Laurent Chofflon, Erik Philipp
  • Method of manufacturing pharmaceutical compositions
    Patent number: 11446251
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: September 20, 2022
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd.
    Inventors: Laurent Chofflon, Erik Philipp
  • METHOD OF MANUFACTURING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220110874
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 14, 2022
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Laurent CHOFFLON, Erik PHILIPP
  • PHARMACEUTICAL COMPOSITION, COMPRISING PHOSPHATE BINDER PARTICLES
    Publication number: 20220110875
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 14, 2022
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Laurent CHOFFLON, Erik PHILIPP
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220105131
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 7, 2022
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Ludwig Daniel WEIBEL, Erik PHILIPP
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220105129
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 7, 2022
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Ludwig Daniel WEIBEL, Erik PHILIPP
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220105130
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 7, 2022
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Ludwig Daniel WEIBEL, Erik PHILIPP
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220072035
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Application
    Filed: April 22, 2021
    Publication date: March 10, 2022
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Ludwig Daniel WEIBEL, Erik PHILIPP
  • Method of manufacturing pharmaceutical compositions
    Patent number: 11234937
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: February 1, 2022
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd.
    Inventors: Laurent Chofflon, Erik Philipp
  • Pharmaceutical composition, comprising phosphate binder particles
    Patent number: 11234938
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: February 1, 2022
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd.
    Inventors: Laurent Chofflon, Erik Philipp
  • Pharmaceutical compositions
    Patent number: 11013761
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: May 25, 2021
    Assignee: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • Pharmaceutical compositions
    Patent number: 11013762
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: May 25, 2021
    Assignee: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20210137973
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 13, 2021
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Ludwig Daniel WEIBEL, Erik PHILIPP
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20210128608
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 6, 2021
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Ludwig Daniel WEIBEL, Erik PHILIPP
  • Pharmaceutical compositions
    Patent number: 10933090
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: March 2, 2021
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • Pharmaceutical compositions
    Patent number: 10925896
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: February 23, 2021
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • Pharmaceutical compositions
    Patent number: 10925897
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: February 23, 2021
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20200345766
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Application
    Filed: July 17, 2020
    Publication date: November 5, 2020
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Ludwig Daniel WEIBEL, Erik PHILIPP